Yangtze River Pharmaceutical Group (hereinafter refers to YRPG) is a large-scale cross-region pharmaceutical group which is one of the key enterprises in China. Founded in 1971, YRPG has been in Top 3 for comprehensive economic benefit in national pharmaceutical industry for over ten years since 1997. In 2010, the total sales revenue reached RMB 25 billion. At present, YRPG has over 8000 employees, with total assets of over RMB 9 billion and a total floor area of over 2 million square meters.And the group owns 7 subsidiaries. Thanks to rich human resources and constant R&D investment, YRPG has established a product structure of 10 series, covering over 10 dosage forms and around 150 products. In the varied pharmaceutical preparations of YRPG, 21 meet USP 34 or BP 2010 standard. Besides, Enalapril Tablets and Omeprazole Capsules are EU-GMP certified; Weisu Granules is recommended to EU market; and Lanqin Oral Solution and Huangqi Oral Solution are awarded Quality System Certificate for Imported & Exported Medicinal Herbs & Preparations.So far, 47 preparations have been exported to Eastern Europe, Asia and Africa, and 70 preparations are under registration in Eastern Europe, Asia, Africa and South America. The short-term goal of YRPG is to become an international manufacturing center, being able to provide high quality services and products in ordinary trade, OEM, brand agent, etc. Every inquiry or collaboration talk is welcomed.